Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cycles

Autor: Leyla Mollamahmutoglu, Berfu Demir, Serdar Dilbaz, Inci Kahyaoglu, Neslihan Yerebasmaz, Altay Guvenir, Sadiman Kiykac Altinbas, Berna Dilbaz
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Luteinizing hormone
Leuprorelin
Pregnancy Rate
Sperm Injections
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
intracytoplasmic sperm injection
Gonadorelin
Antagonists and inhibitors
Hormone antagonist
Procedures
In-vitro fertilization
Gonadotropin-Releasing Hormone
Follicular phase
0302 clinical medicine
Endocrinology
Pregnancy
GnRH antagonist
Medicine
Ganirelix
GnRH agonist
reproductive and urinary physiology
Progesterone
Priority journal
Analogs and derivatives
030219 obstetrics & reproductive medicine
Estradiol
Progesterone in Late Follicular Phase and Pregnancy Rates
Incidence
Follicle stimulating hormone
Obstetrics and Gynecology
Gonadotropin-releasing hormone
Embryo transfer
Intracytoplasmic
Chorionic gonadotropin
Blood
Follicular Phase
in-vitro fertilization
Female
hormones
hormone substitutes
and hormone antagonists

Human
Agonist
Adult
medicine.medical_specialty
endocrine system
medicine.drug_class
Ovulation induction
Case control study
Major clinical study
Case-control studies
Luteal phase
progesterone
Article
Intracytoplasmic sperm injection
03 medical and health sciences
Hormone Antagonists
Ovulation Induction
Internal medicine
Humans
Sperm Injections
Intracytoplasmic

Cetrorelix
In vitro fertilisation
urogenital system
business.industry
Fertilization in vitro
Antagonist
Hormone antagonists
Luteinizing Hormone
Follitropin
Embryo Transfer
Pregnancy rate
030104 developmental biology
Case-Control Studies
Progesterone blood level
Follicle Stimulating Hormone
Leuprolide
business
Controlled study
Gonadorelin agonist
Zdroj: Gynecological Endocrinology
Popis: Objective: The aim of the presented study is to investigate the impact of progesterone change in the late follicular phase on the pregnancy rates of both agonist and antagonist protocols in normoresponders. Study design: A total of 201 normoresponder patients, who underwent embryo transfer were consecutively selected. 118 patients were stimulated using a long luteal GnRH agonist protocol and 83 using a flexible antagonist protocol. The level of change in late follicular phase progesterone was calculated according to the progesterone levels on the hCG day and pre-hCG day (1 or 2 days prior to hCG day) measurement. Results: Clinical pregnancy rates were comparable between long luteal and antagonist group (35.6 and 41%, respectively). The incidence of progesterone elevation on the hCG day was 11% in long luteal and 18% in antagonist group (p = 0.16). In pregnant cycles, p levels both on the hCG day and pre-hCG day measurement were significantly higher in antagonist than agonist cycles (p = 0.029, p = 0.038, respectively). The change of p level was statistically significant in non-pregnant cycles both for the agonist (-0.17 ± 0.07; 95% CI: −0.29 to −0.37) and antagonist groups (−0.18 ± 0.07; 95%CI: −0.31 to −0.04). Conclusions: Late follicular phase progesterone levels were stable during the cycles of pregnant patients irrespective of the protocols and were shown to be higher in pregnant patients in antagonist cycles when compared to agonist cycles.
Databáze: OpenAIRE